Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients with advanced NSCLC and high (≥50%) PD-L1 expression
Read More
Signatera
Resources related to Signatera residual disease testing from a simple drop of blood.
-
-
Signatera NSCLC Data Sheet
Read More
-
Detect. Monitor. Optimize: Signatera’s Impact on Breast Cancer Management
Learn more about the latest Signatera™ data in high-risk breast cancer: Newly published data from the I-SPY 2 trial reinforcing the utility of ctDNA monitoring
Watch Video
-
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer
Read More
-
HIPAA Authorization to Release Records to a Partner/Significant-other
Read More
-
Post-ASCO Summary: ctDNA as a patient selection and early efficacy marker in drug development
Our expert speakers will discuss the latest data from ASCO 2023 and other recent publications and congresses. This will be followed by a panel discussion on the future directions and implications for
Watch Video
-
Powering Precision: The essential role of ctDNA testing for MRD assessment in GI malignancies
In this webinar, we explore how ctDNA can help bring clarity to common clinical scenarios including adjuvant treatment decision making, indeterminate findings and assessing treatment response.
Watch Video
-
SGO 2023 - Post-surgical ctDNA-based Molecular Residual Disease Detection in Patients with Stage I Endometrial Malignancies
Read More
-
SGO 2023 - Immunotherapy response monitoring using personalized circulating tumor DNA analysis
Read More
-
Breast Cancer Patient Discussion Guide
Read More
-
Breast Cancer Patient Brochure
Read More
-
Signatera CRC Brochure
Read More
-
Signatera IO One Sheet
Read More
-
Circulate Japan Sales Aid
Read More
-
Oncology Pan Portfolio
Read More
-
Signatera Melanoma Data Sheet
Read More
-
Signatera Pan Tumor Guide
Read More
-
SABCS 2022 Product Theater Section 1 - The Cycle of ctDNA in Breast Cancer
Watch Video
-
SABCS 2022 Product Theater
Watch Video
-
SABCS 2022 Product Theater Section 5 - Limitations and Eblis
Clinical Applications for Signatera in Breast Cancer Surveillance
Watch Video
-
Loading More...
